Multicentric, transversal, descriptive, epidemiological study on the management of asthma in asthmatic Middle East adult population - ESMAA
Study identifier:NIS-RME-XXX-2014/1
ClinicalTrials.gov identifier:NCT02153411
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluation of aSthma Management in Middle EAst Adult population
Medical condition
asthma
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
7294
Study type
Observational
Age
18 Years - 130 Years
Date
Study Start Date: 01 Jun 2014
Primary Completion Date: 01 Dec 2015
Study Completion Date: 01 Dec 2015
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 8645 asthmatic patients Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained. | - |
